A preliminary study for the treatment of cervical colposcopic lesions with the biological compound AV2.

@article{Martinez2017APS,
  title={A preliminary study for the treatment of cervical colposcopic lesions with the biological compound AV2.},
  author={G. Martinez and B A Mutombo and V{\'i}ctor L. Fern{\'a}ndez and Jeane Pierre Van Geertruyden and Yves Jacquemyn},
  journal={European journal of gynaecological oncology},
  year={2017},
  volume={38 3},
  pages={342-345}
}
OBJECTIVE To evaluate the efficacy of Anti Viral 2 (AV2) in the regression of moderate and severe colposcopic lesions, when com- pared to placebo. MATERIALS AND METHODS Women, aged over 18 years with a colposcopic diagnosis of moderate to severe dysplasia were randomized to receive either two applications of AV2 or placebo within four days. Both examining… CONTINUE READING